Skip to main content
Premium Trial:

Request an Annual Quote

Glenn Crocker, Pachiappan Manickham, Anne Pilaro, Simon Tavar, Mark Caccavo, Gregory Lucier

Premium

Glenn Crocker was named the first chief executive of BioCity Nottingham, UK. Crocker previously was head of the UK biotechnology practice for the firm of Ernst & Young. He holds a PhD in immunology from Oxford University.

 

Pachiappan Manickham will direct the new microarray core service facility at the Blanchette Rockefeller Neurosciences Institute at Johns Hopkins University Shady Grove Campus in Gaithersburg, Md.

 

Anne Pilaro has joined Gaithersburg, Md.-based Gene Logic as senior director for regulatory affairs for subsidiary TherImmune Research. Pilaro was expert toxicologist for cellular and gene therapies with the Office of Therapeutics Research of the Food and Drug Administration.

 

Simon Tavaré, professor of biology, mathematics, and preventative medicine at the University of Southern California, has joined the scientific advisory board of BioDiscovery of Marina Del Rey, Calif. He is also a professor-at-large at the Keck Graduate Institute for Applied Life Sciences in Claremont, Calif. He holds a PhD in probability and statistics from the University of Sheffield, UK.

 

Mark Caccavo joins the derivatives unit of the investment bank of CE Unterberg, Towbin of New York, which services a life sciences clientele. Caccavo previously was a vice president for Charles Schwab.

 

Gregory Lucier was named president and CEO of Carlsbad, Calif.-based Invitrogen, the company said last week. Lucier previously was president and CEO of General Electric’s Medical Systems Information Technologies unit. Lucier holds an MBA degree from Harvard University and a bachelor’s degree in industrial engineering from Pennsylvania State University.

 

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.